Both nominators and nominees must be AIMBE Fellows and in good standing with the organization. Nominators shall provide the name, contact details, and maximum 35-word citation. Nominators must submit a 2-page description of the candidate’s contributions meriting the award, a 2-page description of the candidate’s biographical sketch as well as up to 3 letters of support (two letters are required). Nominations require a CV (5 pages max) that highlights the nominee’s accomplishments that are relevant to the award.
Nominations should provide specific metrics to support the candidate’s impact (personal anecdotes will not be considered). The letters of support must be from individuals with direct knowledge of the impact for which the candidate is nominated and must be from individuals other than the nominator.
Individual recipients receiving an award will be recognized at the Awards Banquet during AIMBE’s Annual Meeting and must be present to accept their award.
The Pierre Galletti Award was established in 1999 by the AIMBE Board of Directors to honor its Founding Member and Past President. The award is presented to an AIMBE Fellow in recognition of his/her contributions to public awareness of medical and biological engineering, and to the promotion of the national interest in science, engineering and education. The Galletti Award is the highest honor that AIMBE bestows on an individual.
Pierre Galletti passed away on March 8, 1997, having left his mark on the emerging field of biomedical engineering. He was a pioneering researcher, making his impact in such fields as heart-lung bypass, artificial organs, and tissue engineering. As a dedicated teacher and mentor, he not only provided leadership in the establishment of the medical school at Brown University, but also helped start Morehouse School of Medicine in Atlanta. He was the consummate biomedical engineer, a person of great vision, a man for all seasons.
For significant contributions to neuroscience data analysis and for characterizing the neurophysiology of anesthesia-induced unconsciousness and demonstrating how it can be reliably monitored in real time using electroencephalogram recordings.
For impactful innovations in technologies to generate, understand, and utilize functional human tissues, especially in regenerative engineering, studies of development and disease, while inspiring the next generation of practitioners.
For his national leadership and service in creating and advancing the field of synthetic biology and for raising public awareness of synthetic biology and biological engineering through extensive outreach activities.
For national and international leadership in the shaping of science and technology policy, and for fundamental advances toward understanding the molecular biomechanics of traumatic injury.
For long-standing, consistent and systematic vision, leadership and accomplishments in the creation of inclusion in medical and biological engineering and for excellence in research in sickle cell disease and cartilage engineering.
For global leadership and exceptional innovation in creating the discipline of global health engineering and pioneering engineering solutions to save countless maternal, newborn and vulnerable lives in resource limited settings.
For seminal contributions to the advancement of human health through research and commercialization of biotech, medical device and diagnostic products, and a unique manner of bridging industry and academic expertise to influence biomedical education training programs and the public policies required to support success of these bench-to-bedside endeavors.
For seminal contributions as a surgeon, inventor, and educator, Dr. Grundfest has demonstrated that minimally invasive technology can improve healthcare delivery while lowering healthcare costs. Through activities with AIMBE, TATRC, NIH, FDA, SPIE, IEEE, OSA, and other medical societies, he has promoted the critical role of medical and biological engineering in healthcare advances.
For seminal contributions to quantitative understanding and treatment of respiratory disease, providing a role model for national growth of the biomedical engineering discipline, mentoring a generation of students, elevating the stature and visibility of AIMBE with key federal agencies and lawmakers, and promoting public awareness of the field through national engineering school and professional society leadership.
For impactful contributions to public awareness of medical and biological engineering and the promotion of the national interest in science, engineering and education in his role as Director of NIBIB and for cutting-edge research in cardiovascular radiology diagnostic and treatment strategies.
For seminal contributions to the design and commercialization of pacemakers, biodegradable biomaterials, and implantable devices, and for leadership in medical and biological engineering and public policy issues.
In recognition of enduring pioneering contributions and inspired leadership in biomaterials science, exceptional mentorship, and tireless promotion of public awareness and national interest in biomedical engineering research and education.
For seminal contributions to biomaterials, medical devices and artifi cial organs and for his visionary leadership of biomedical education and research over the last 60 years.
For seminal contributions to tissue engineering and leadership in international biomedical engineering.
For seminal contributions and visionary leadership in biomaterials science and engineering, and for pioneering work on drug delivery that has led to numerous biomedical products and devices.
For training a generation of bioengineering faculty, establishing an innovative Biological Engineering program at MIT, writing a seminal text on receptors and exemplary service to Bioengineering Societies.
For outstanding leadership in bioengineering and education, helping to establish numerous bioengineering departments in universities across the country, and seminal research on the control of the cardiovascular and respiratory systems.
For pioneering research and outstanding leadership in the bioengineering field and for transforming the bioengineering program at the University of California San Diego into one of the best in the country.
For tireless promotion of biomedical engineering, numerous contributions to hemodynamics and cardiovascular-tissue engineering, and playing a crucial role in establishing AIMBE and the National Institute of Biomedical Imaging and Bioengineering.
For continuous advocacy of bioengineering which led to increased public awareness of the field and the formation of the Bioengineering Consortium and pivotal work on cardiovascular devices.
For innovative and seminal contributions to biomaterials science and tissue engineering, inspiring and training a generation of bioengineers, and exhaustive work in raising public awareness of bioengineering.